CAT and metabolic dysfunction-associated steatotic liver disease: Świderska et al. reported that serum CAT activities in early and advanced MASLD groups were decreased as compared to healthy controls (Świderska et al. 2019), whereas a research study by Perlemuter et al. showed no differences in CAT activity in erythrocytes (Perlemuter et al. 2005).